WALOVI's International Cans Make Global Debut, Ushering in a New Era of Eastern Natural Plant Beverages
Mr. Ye Jizeng, Vice General Manager of Guangzhou Wang Lao Ji Great Health Industry Co., Ltd., highlighted two major trends in the global beverage market: the rise of healthy and natural beverages, and the growing demand for low-sugar/sugar-free options. He emphasized that as an original Chinese beverage with a 197-year history, WALOVI remains committed to natural ingredients and health-oriented principles. Over the next three years, WALOVI plans to build multiple overseas markets with sales exceeding RMB 100 million each.
"We will establish model markets for deep distribution and brand building. Today's launch is a strategic milestone in our global blueprint, with systematic preparations across product development, brand enhancement, channel expansion, and supply chain optimization. WALOVI will make the world believe that: Natural is the direction of flavor, healthy offers choice of good tasting."
According to Frost & Sullivan, WALOVI has ranked first in global plant beverage sales for five consecutive years. Domestically, it holds nearly 50% of the plant drink market share. Over the past decade, the brand's overseas market presence has expanded 6.5-fold, with an annual compound growth rate exceeding 25%.
At the event, Wanglaoji signed agreements with the first batch of partners of WALOVI, including Meituan Delivery, Eleme, Dianping, Ocean Engine, and Jiaye Trading Canada Corp. The new WALOVI products will soon be available across Southeast Asia, North America, Europe, and Oceania.
Through its systematic Product-Channel-Brand-Culture (PCBC) global strategy, Wanglaoji is committed to offering sustainable and healthy choices to the world with its natural Eastern plant beverages. With WALOVI, the brand aims to reshape the global beverage landscape, offering healthier alternatives and fostering cultural exchange through consumption.
View original content to download multimedia:https://www.prnewswire.com/news-releases/walovis-international-cans-make-global-debut-ushering-in-a-new-era-of-eastern-natural-plant-beverages-302535560.html
SOURCE Guangzhou Wang Lao Ji Great Health Industry Co., Ltd.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2025/21/c6646.html
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
7 minutes ago
- Bloomberg
China Gen Z Stocks Surge Anew as Earnings Reignite Investor Buzz
Stocks of Chinese companies popular with Gen Z are surging again, fueled by robust earnings and fervent demand of young consumers. A set of bumper results, coupled with an equally promising outlook, may be providing the tailwind for the shares of toys, bubble tea and jewelery makers catering to the emotional quotient of the generation of people born between the late 1990s and the early 2010s.
Yahoo
36 minutes ago
- Yahoo
Asian Market Value Picks Trading Below Estimated Worth In August 2025
As global markets navigate the complexities of inflation data and interest rate speculations, Asian indices have shown resilience, with Japan's stock markets reaching record highs and Chinese stocks advancing amid renewed trade negotiations. In such an environment, identifying undervalued stocks becomes crucial as investors seek opportunities that may offer potential growth despite broader economic uncertainties. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Xi'an NovaStar Tech (SZSE:301589) CN¥160.67 CN¥312.31 48.6% Sunjin Beauty ScienceLtd (KOSDAQ:A086710) ₩10720.00 ₩21037.18 49% SRE Holdings (TSE:2980) ¥3115.00 ¥6106.05 49% SK Biopharmaceuticals (KOSE:A326030) ₩97200.00 ₩189933.83 48.8% Matsuya R&DLtd (TSE:7317) ¥717.00 ¥1428.98 49.8% Lotes (TWSE:3533) NT$1350.00 NT$2686.73 49.8% Kolmar Korea (KOSE:A161890) ₩79600.00 ₩155807.48 48.9% Jiangxi Rimag Group (SEHK:2522) HK$19.16 HK$37.57 49% Fositek (TWSE:6805) NT$1060.00 NT$2092.67 49.3% EROAD (NZSE:ERD) NZ$2.35 NZ$4.63 49.2% Click here to see the full list of 269 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Dekon Food and Agriculture Group Overview: Dekon Food and Agriculture Group operates in the livestock and poultry breeding and farming sectors, with a market cap of HK$34.42 billion. Operations: The company's revenue is primarily derived from the sales of pigs (CN¥21.32 billion), poultry (CN¥3.07 billion), and ancillary products (CN¥6.12 billion). Estimated Discount To Fair Value: 44.3% Dekon Food and Agriculture Group is trading at HK$88.5, significantly below its estimated fair value of HK$159.01, suggesting it may be undervalued based on cash flows. Despite recent volatility in share price and a decline in net income for the first half of 2025, the company expects substantial profit growth due to improved management efficiency and reduced pig costs. Revenue growth is projected to outpace the Hong Kong market, reinforcing its value proposition. The growth report we've compiled suggests that Dekon Food and Agriculture Group's future prospects could be on the up. Get an in-depth perspective on Dekon Food and Agriculture Group's balance sheet by reading our health report here. InnoCare Pharma Overview: InnoCare Pharma Limited is a biopharmaceutical company focused on discovering, developing, and commercializing drugs for cancer and autoimmune diseases in China, with a market cap of HK$37.30 billion. Operations: InnoCare Pharma Limited generates revenue by discovering, developing, and commercializing therapeutic drugs targeting cancer and autoimmune diseases within the Chinese market. Estimated Discount To Fair Value: 22.2% InnoCare Pharma, trading at HK$19.05, is undervalued with a fair value estimate of HK$24.49, reflecting over 20% potential upside based on cash flows. The company's revenue grew significantly to CNY 731.43 million for H1 2025 from CNY 419.74 million a year ago, while net losses narrowed considerably to CNY 30.09 million from CNY 261.84 million, driven by robust oncology pipelines and innovative drug development efforts in solid tumors and hematologic malignancies. In light of our recent growth report, it seems possible that InnoCare Pharma's financial performance will exceed current levels. Click here to discover the nuances of InnoCare Pharma with our detailed financial health report. Kinik Overview: Kinik Company produces and sells abrasives, cutting tools, and reclaimed wafers both in Taiwan and internationally, with a market cap of approximately NT$47.92 billion. Operations: The company's revenue is divided into two main segments: The Electronics Sector, generating NT$3.73 billion, and The Traditional Sectors, contributing NT$3.85 billion. Estimated Discount To Fair Value: 43.6% Kinik, trading at NT$327, is undervalued with a fair value estimate of NT$579.61. The company's earnings are projected to grow significantly at 32.7% annually, outpacing the TW market's 15.4%. Recent results show sales increased to TWD 2.11 billion in Q2 2025 from TWD 1.73 billion a year ago, with net income rising modestly to TWD 266.37 million from TWD 253.67 million, reflecting strong operational performance amidst favorable cash flow valuations. According our earnings growth report, there's an indication that Kinik might be ready to expand. Take a closer look at Kinik's balance sheet health here in our report. Next Steps Delve into our full catalog of 269 Undervalued Asian Stocks Based On Cash Flows here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2419 SEHK:9969 and TWSE:1560. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
36 minutes ago
- Yahoo
US Defense Department to buy cobalt for up to $500 million
(Reuters) -The U.S. is seeking to procure cobalt worth up to $500 million for defense stockpiles amid the country's move to boost its critical mineral supplies. Companies have been scrambling to source rare earths after China imposed restrictions, leading to a 75% drop in rare earth magnet exports from the country in June and causing some auto companies to suspend production. U.S. President Donald Trump in March invoked emergency powers to boost domestic production of critical minerals as part of a broad effort to offset China's near-total control of the sector. In July, Reuters reported that the White House tapped a former mining executive, David Copley, to head an office at the National Security Council focused on strengthening supply chains. According to the tender document published by the U.S. Department of Defense and the Defense Logistics Agency (DLA) on Wednesday, they are looking for offers for alloy-grade cobalt of about 7,480 tonnes over the next five years. Cobalt, mostly imported by the U.S., is used in batteries, a component in nickel superalloys for high temperature sections of jet engines and industrial gas turbines, among others. However, the defense department was seeking offers from only three companies - units of Vale SA in Canada, Japan's Sumitomo Metal Mining and Norway's Glencore Nikkelverk. The document also said the purchase amount can range from between $2 million and $500 million in the five-year period. Sign in to access your portfolio
